24,211 XNAS Volume
XNAS 04 Apr, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| C. Randal Mills | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 27,083 | 299,999 | - | - | Class A Common Stock | |
| C. Randal Mills | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.00 per share. | 10 Mar 2025 | 10,706 | 289,293 | - | 3 | 32,118 | Class A Common Stock |
| C. Randal Mills | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 27,083 | 352,083 | - | - | Restricted Stock Units | |
| Michelle Leroux Williams | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 12,500 | 87,500 | - | - | Restricted Stock Units | |
| Michelle Leroux Williams | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.00 per share. | 10 Mar 2025 | 4,613 | 76,286 | - | 3 | 13,839 | Class A Common Stock |
| Michelle Leroux Williams | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 12,500 | 80,899 | - | - | Class A Common Stock | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2025 | 16,500 | 16,500 | - | - | Restricted Stock Units | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2025 | 1,287 | 0 | - | - | Restricted Stock Units | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2025 | 1,287 | 320,031 | - | - | Class A Common Stock | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.77 per share. | 08 Mar 2025 | 528 | 325,263 | - | 2.8 | 1,463 | Class A Common Stock |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2025 | 29,000 | 354,263 | - | - | Class A Common Stock | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.00 per share. | 08 Mar 2025 | 11,885 | 342,378 | - | 3 | 35,655 | Class A Common Stock |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2025 | 12,500 | 87,500 | - | - | Restricted Stock Units | |
| C. Randal Mills | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 27,083 | 281,024 | - | - | Class A Common Stock | |
| C. Randal Mills | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 27,083 | 379,166 | - | - | Restricted Stock Units | |
| C. Randal Mills | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.29 per share. | 10 Dec 2024 | 13,726 | 267,298 | - | 4.3 | 58,885 | Class A Common Stock |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 12,500 | 100,000 | - | - | Restricted Stock Units | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.29 per share. | 10 Dec 2024 | 4,461 | 318,744 | - | 4.3 | 19,138 | Class A Common Stock |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 12,500 | 323,205 | - | - | Class A Common Stock | |
| Michelle Leroux Williams | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.29 per share. | 10 Dec 2024 | 3,950 | 68,399 | - | 4.3 | 16,946 | Class A Common Stock |
| Michelle Leroux Williams | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 12,500 | 100,000 | - | - | Restricted Stock Units | |
| Michelle Leroux Williams | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 12,500 | 72,349 | - | - | Class A Common Stock | |
| C. Randal Mills | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 27,084 | 263,605 | - | - | Class A Common Stock | |
| C. Randal Mills | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 27,084 | 406,249 | - | - | Restricted Stock Units | |
| C. Randal Mills | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.14 per share. | 10 Sep 2024 | 9,664 | 253,941 | - | 4.1 | 40,009 | Class A Common Stock |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.14 per share. | 10 Sep 2024 | 10,527 | 310,705 | - | 4.1 | 43,582 | Class A Common Stock |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 17,000 | 33,000 | - | - | Restricted Stock Units | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 12,500 | 112,500 | - | - | Restricted Stock Units | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 29,500 | 321,232 | - | - | Class A Common Stock | |
| Michelle Leroux Williams | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.14 per share. | 10 Sep 2024 | 3,951 | 59,849 | - | 4.1 | 16,357 | Class A Common Stock |
| Michelle Leroux Williams | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 12,500 | 112,500 | - | - | Restricted Stock Units | |
| Michelle Leroux Williams | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 12,500 | 63,800 | - | - | Class A Common Stock | |
| C. Randal Mills | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 162,500 | 0 | - | - | Restricted Stock Units | |
| C. Randal Mills | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 162,500 | 292,467 | - | - | Class A Common Stock | |
| C. Randal Mills | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.84 per share. | 12 Aug 2024 | 58,659 | 233,808 | - | 2.8 | 166,592 | Class A Common Stock |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.84 per share. | 12 Aug 2024 | 17,840 | 289,983 | - | 2.8 | 50,666 | Class A Common Stock |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 50,000 | 0 | - | - | Restricted Stock Units | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 50,000 | 307,823 | - | - | Class A Common Stock | |
| Michelle Leroux Williams | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.84 per share. | 12 Aug 2024 | 15,800 | 51,300 | - | 2.8 | 44,872 | Class A Common Stock |
| Michelle Leroux Williams | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 50,000 | 67,100 | - | - | Class A Common Stock | |
| Michelle Leroux Williams | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 50,000 | 0 | - | - | Restricted Stock Units | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2024 | 105,080 | 0 | - | - | Warrants (rights to buy) | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.43 per share. | 31 Jul 2024 | 105,080 | 257,823 | - | 1.4 | 150,002 | Class A Common Stock |
| C. Randal Mills | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2024 | 22,473 | 137,986 | - | - | Class A Common Stock | |
| C. Randal Mills | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2024 | 22,473 | 44,946 | - | - | Restricted Stock Units | |
| C. Randal Mills | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.50 per share. | 21 Jun 2024 | 8,019 | 129,967 | - | 3.5 | 28,067 | Class A Common Stock |
| C. Randal Mills | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 54,167 | 134,840 | - | - | Class A Common Stock | |
| C. Randal Mills | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 54,167 | 433,333 | - | - | Restricted Stock Units | |
| C. Randal Mills | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.47 per share. | 10 Jun 2024 | 19,327 | 115,513 | - | 3.5 | 67,065 | Class A Common Stock |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.47 per share. | 10 Jun 2024 | 8,920 | 152,743 | - | 3.5 | 30,952 | Class A Common Stock |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 25,000 | 161,663 | - | - | Class A Common Stock | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 25,000 | 125,000 | - | - | Restricted Stock Units | |
| Michelle Leroux Williams | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 25,000 | 25,000 | - | - | Class A Common Stock | |
| Michelle Leroux Williams | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 25,000 | 125,000 | - | - | Restricted Stock Units | |
| Michelle Leroux Williams | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.47 per share. | 10 Jun 2024 | 7,900 | 17,100 | - | 3.5 | 27,413 | Class A Common Stock |
| Brigid A. Makes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 31,835 | 31,835 | - | - | Stock Option (Right to Buy) | |
| Kevin Rakin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 47,753 | 47,753 | - | - | Stock Option (Right to Buy) | |
| Maybelle Jordan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 31,835 | 31,835 | - | - | Stock Option (Right to Buy) | |
| David Colpman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 31,835 | 31,835 | - | - | Stock Option (Right to Buy) | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 1,288 | 1,287 | - | - | Restricted Stock Units | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.24 per share. | 08 Mar 2024 | 528 | 121,279 | - | 3.2 | 1,711 | Class A Common Stock |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 1,288 | 121,807 | - | 0 | Class A Common Stock | |
| Leroux Michelle Williams | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 150,000 | 150,000 | - | - | Restricted Stock Units | |
| Ferguson B. Matthew | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 50,000 | 50,000 | - | - | Restricted Stock Units | |
| Randal C. Mills | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 182,511 | 182,511 | - | - | Stock Option (Right to Buy) | |
| C. Randal Mills | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 487,500 | 487,500 | - | - | Stock Option (Right to Buy) | |
| Randal Mills C. | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 89,894 | 89,894 | - | - | Restricted Stock Units | |
| Matthew Ferguson B. | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 150,000 | 150,000 | - | - | Restricted Stock Units | |
| C. Mills Randal | Director, PRESIDENT AND CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Jan 2024 | 89,894 | 0 | - | - | Restricted Stock Units | |
| C. Randal Mills | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 487,500 | 487,500 | - | - | Restricted Stock Units | |
| Mills Randal C. | Director, PRESIDENT AND CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Jan 2024 | 182,511 | 0 | - | - | Stock Option (Right to Buy) | |
| Williams Leroux Michelle | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| C. Randal Mills | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.41 per share. | 21 Jun 2023 | 7,772 | 62,710 | - | 2.4 | 18,731 | Class A Common Stock |
| C. Randal Mills | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2023 | 22,474 | 70,482 | - | - | Class A Common Stock | |
| C. Randal Mills | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2023 | 22,474 | 67,419 | - | - | Restricted Stock Units | |
| Brigid A. Makes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Maybelle Jordan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| David Colpman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| C. Randal Mills | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2023 | 44,947 | 89,893 | - | - | Restricted Stock Units | |
| C. Randal Mills | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2023 | 44,947 | 48,008 | - | 0 | Class A Common Stock | |
| C. Randal Mills | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 134,840 | 134,840 | - | - | Restricted Stock Units | |
| C. Randal Mills | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 89,894 | 89,894 | - | - | Restricted Stock Units | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 1,287 | 46,504 | - | 0 | Class A Common Stock | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 1,287 | 2,575 | - | - | Restricted Stock Units | |
| Thomas Englese | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 937 | 1,875 | - | - | Restricted Stock Units | |
| Thomas Englese | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 4.30 per share. | 08 Mar 2023 | 289 | 17,917 | - | 4.3 | 1,243 | Class A Common Stock |
| Thomas Englese | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 937 | 18,206 | - | 0 | Class A Common Stock | |
| David Colpman | Director | Purchase of securities on an exchange or from another person at price $ 3.90 per share. | 15 Dec 2022 | 3,098 | 3,098 | - | 3.9 | 12,082 | Class A Common Stock |
| Brigid A. Makes | Director | Purchase of securities on an exchange or from another person at price $ 3.65 per share. | 09 Dec 2022 | 2,000 | 2,000 | - | 3.7 | 7,300 | Class A Common Stock |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 4.03 per share. | 02 Dec 2022 | 6,000 | 23,217 | - | 4.0 | 24,180 | Class A Common Stock |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 4.75 per share. | 02 Dec 2022 | 20,000 | 43,217 | - | 4.8 | 95,000 | Class A Common Stock |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 3.61 per share. | 02 Dec 2022 | 2,000 | 45,217 | - | 3.6 | 7,220 | Class A Common Stock |
| David Colpman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2022 | 28,513 | 28,513 | - | - | Stock Option (Right to Buy) | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2022 | 13,874 | 22,015 | - | - | Class A Common Stock | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2022 | 13,874 | 0 | - | - | Restricted Stock Units | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.30 per share. | 08 Sep 2022 | 4,798 | 17,217 | - | 7.3 | 35,025 | Class A Common Stock |
| Peter G. Edwards | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2022 | 4,625 | 0 | - | - | Restricted Stock Units | |
| Peter G. Edwards | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2022 | 4,625 | 4,625 | - | - | Class A Common Stock | |
| Peter G. Edwards | GENERAL COUNSEL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.30 per share. | 08 Sep 2022 | 1,127 | 3,498 | - | 7.3 | 8,227 | Class A Common Stock |
| Thomas Englese | CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.30 per share. | 08 Sep 2022 | 4,728 | 17,269 | - | 7.3 | 34,514 | Class A Common Stock |
| Thomas Englese | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2022 | 15,390 | 0 | - | - | Restricted Stock Units | |
| Thomas Englese | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2022 | 15,390 | 21,997 | - | - | Class A Common Stock | |
| Jerome Riebman | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2022 | 14,758 | 20,093 | - | - | Class A Common Stock | |
| Jerome Riebman | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2022 | 14,758 | 0 | - | - | Restricted Stock Units | |
| Jerome Riebman | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.30 per share. | 08 Sep 2022 | 5,104 | 14,989 | - | 7.3 | 37,259 | Class A Common Stock |
| C. Randal Mills | Director, Interim President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 182,511 | 182,511 | - | - | Stock Option (Right to Buy) | |
| C. Randal Mills | Director, Interim President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 273,767 | 273,767 | - | - | Stock Option (Right to Buy) | |
| Brigid A. Makes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 22,090 | 22,090 | - | - | Stock Option (Right to Buy) | |
| C. Randal Mills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 22,090 | 22,090 | - | - | Stock Option (Right to Buy) | |
| Maybelle Jordan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 22,090 | 22,090 | - | - | Stock Option (Right to Buy) | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 8,700 | 8,700 | - | - | Restricted Stock Units | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 1,288 | 8,140 | - | 0 | Class A Common Stock | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 31,000 | 31,000 | - | - | Stock Option (Right to Buy) | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 13,874 | 13,874 | - | - | Restricted Stock Units | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 1,288 | 3,862 | - | - | Restricted Stock Units | |
| Ronald K. Lloyd | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 39,894 | 39,894 | - | - | Restricted Stock Units | |
| Ronald K. Lloyd | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 37,788 | 37,788 | - | - | Restricted Stock Units | |
| Ronald K. Lloyd | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 138,770 | 138,770 | - | - | Stock Option (Right to Buy) | |
| Ronald K. Lloyd | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 4,072 | 31,775 | - | 0 | Class A Common Stock | |
| Ronald K. Lloyd | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 4,072 | 12,216 | - | - | Restricted Stock Units | |
| Peter G. Edwards | GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 31,000 | 31,000 | - | - | Stock Option (Right to Buy) | |
| Peter G. Edwards | GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 8,700 | 8,700 | - | - | Restricted Stock Units | |
| Peter G. Edwards | GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 4,625 | 4,625 | - | - | Restricted Stock Units | |
| Thomas Englese | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 15,390 | 15,390 | - | - | Restricted Stock Units | |
| Thomas Englese | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 938 | 2,812 | - | - | Restricted Stock Units | |
| Thomas Englese | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 8,700 | 8,700 | - | - | Restricted Stock Units | |
| Thomas Englese | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 31,000 | 31,000 | - | - | Stock Option (Right to Buy) | |
| Thomas Englese | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 08 Mar 2022 | 276 | 6,607 | - | - | Class A Common Stock | |
| Thomas Englese | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 938 | 6,883 | - | 0 | Class A Common Stock | |
| Jerome Riebman | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 782 | 5,334 | - | 0 | Class A Common Stock | |
| Jerome Riebman | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 14,758 | 14,758 | - | - | Restricted Stock Units | |
| Jerome Riebman | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 782 | 2,343 | - | - | Restricted Stock Units | |
| Jerome Riebman | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 8,700 | 8,700 | - | - | Restricted Stock Units | |
| Jerome Riebman | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 31,000 | 31,000 | - | - | Stock Option (Right to Buy) | |
| Darryl Roberts | EVP, OPERATIONS & PRODUCT DEV. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 17,024 | 17,024 | - | - | Restricted Stock Units | |
| Darryl Roberts | EVP, OPERATIONS & PRODUCT DEV. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 938 | 2,812 | - | - | Restricted Stock Units | |
| Darryl Roberts | EVP, OPERATIONS & PRODUCT DEV. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 10,440 | 10,440 | - | - | Restricted Stock Units | |
| Darryl Roberts | EVP, OPERATIONS & PRODUCT DEV. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 37,200 | 37,200 | - | - | Stock Option (Right to Buy) | |
| Darryl Roberts | EVP, OPERATIONS & PRODUCT DEV. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 938 | 3,329 | - | 0 | Class A Common Stock | |
| Thomas Englese | CHIEF COMMERCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 6.10 per share. | 14 Dec 2021 | 4,580 | 5,088 | - | 6.1 | 27,938 | Class A Common Stock |
| Peter G. Edwards | GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2021 | 96,200 | 96,200 | - | - | Stock Option (Right to Buy) | |
| Brigid A. Makes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 14,082 | 14,082 | - | - | Stock Option (Right to Buy) | |
| C. Randal Mills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 14,082 | 14,082 | - | - | Stock Option (Right to Buy) | |
| Maybelle Jordan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 14,082 | 14,082 | - | - | Stock Option (Right to Buy) | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 11.14 per share. | 10 May 2021 | 1,300 | 1,300 | - | 11.1 | 14,482 | Class A Common Stock |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 11.00 per share. | 10 May 2021 | 1,000 | 2,300 | - | 11 | 11,000 | Class A Common Stock |
| Ronald K. Lloyd | Director, PRESIDENT AND CEO | Purchase of securities on an exchange or from another person at price $ 12.28 per share. | 07 May 2021 | 1,367 | 23,151 | - | 12.3 | 16,787 | Class A Common Stock |
| Ronald K. Lloyd | Director, PRESIDENT AND CEO | Purchase of securities on an exchange or from another person at price $ 11.65 per share. | 07 May 2021 | 7,198 | 21,784 | - | 11.7 | 83,857 | Class A Common Stock |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 30,900 | 30,900 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 5,150 | 5,150 | - | - | RESTRICTED STOCK UNITS | |
| Ronald K. Lloyd | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 16,288 | 16,288 | - | - | RESTRICTED STOCK UNITS | |
| Ronald K. Lloyd | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 97,725 | 97,725 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Thomas Englese | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 22,500 | 22,500 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Thomas Englese | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 3,750 | 3,750 | - | - | RESTRICTED STOCK UNITS | |
| Jerome Riebman | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 18,750 | 18,750 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Jerome Riebman | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 3,125 | 3,125 | - | - | RESTRICTED STOCK UNITS | |
| Darryl Roberts | EVP, OPERATIONS & PRODUCT DEV. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 3,750 | 3,750 | - | - | RESTRICTED STOCK UNITS | |
| Darryl Roberts | EVP, OPERATIONS & PRODUCT DEV. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 22,500 | 22,500 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Brigid A. Makes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2020 | 14,307 | 14,307 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| C. Randal Mills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2020 | 14,307 | 14,307 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Maybelle Jordan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2020 | 14,307 | 14,307 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Ronald K. Lloyd | Director, President and CEO | 13 Oct 2020 | 14,586 | 14,586 | - | 0 | Class A Common Stock | ||
| Ronald K. Lloyd | Director, President and CEO | 13 Oct 2020 | 111,788 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Matthew B. Ferguson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2020 | 81,800 | 81,800 | - | - | Stock Option (Right to Buy) | |
| Ronald K. Lloyd | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2020 | 181,783 | 181,783 | - | - | Stock Option (Right to Buy) | |
| Ronald K. Lloyd | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2020 | 100,425 | 100,425 | - | - | Restricted Stock Units | |
| Thomas Englese | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2020 | 33,488 | 33,488 | - | - | Stock Option (Right to Buy) | |
| Thomas Englese | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2020 | 13,890 | 13,890 | - | - | Restricted Stock Units | |
| Jerome Riebman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2020 | 30,412 | 30,412 | - | - | Stock Option (Right to Buy) | |
| Jerome Riebman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2020 | 10,186 | 10,186 | - | - | Restricted Stock Units | |
| Darryl Roberts | EVP, Operations & Product Deve | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2020 | 50,083 | 50,083 | - | - | Stock Option (Right to Buy) | |
| Darryl Roberts | EVP, Operations & Product Deve | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2020 | 11,112 | 11,112 | - | - | Restricted Stock Units |